Drugs / DWC202518
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07619833 | Jun 2026 → Nov 2027 expected | type 2 diabetes mellitus | Daewoong Pharmaceutical Co. LTD. | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DWC202518 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07619833 ↗ |
| Route | Oral | “Orally” NCT07619833 ↗ |